Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease
- PMID: 20303728
- PMCID: PMC3860361
- DOI: 10.1016/j.jnutbio.2009.11.009
Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the US and refers to a wide spectrum of liver damage, including simple steatosis, steatohepatitis, fibrosis and cirrhosis. The goal of the present study was to achieve a more detailed understanding of the molecular changes in response to high fat-induced liver steatosis through the identification of a differentially expressed liver transcriptome and proteome. Male C57/BL6 mice fed a high-fat lard diet for 8 weeks developed visceral obesity and hepatic steatosis characterized by significantly increased liver and plasma free fatty acid and triglyceride levels and plasma alanine aminotransferase activities. Transcriptome analysis demonstrated that, compared to the control diet (CD), high-fat diet changed the expression of 309 genes (132 up- and 177 down-regulated; by a twofold change and more, P<.05). Multiple genes encoding proteins involved in lipogenesis were down-regulated, whereas genes involved in fatty acid oxidation were up-regulated. Proteomic analysis revealed 12 proteins which were differentially expressed. Of these, glutathione S-transferases mu1 and pi1 and selenium-binding protein 2 were decreased at both the gene and protein levels. This is the first study to perform a parallel transcriptomic and proteomic analysis of diet-induced hepatic steatosis. Several key pathways involving xenobiotic and lipid metabolism, the inflammatory response and cell-cycle control were identified. These pathways provide targets for future mechanistic and therapeutic studies as related to the development and prevention of NAFLD.
Copyright © 2011. Published by Elsevier Inc.
Figures
Similar articles
-
Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.Lipids Health Dis. 2013 Nov 4;12:165. doi: 10.1186/1476-511X-12-165. Lipids Health Dis. 2013. PMID: 24188280 Free PMC article.
-
Differential expression of intermediate filaments in the process of developing hepatic steatosis.Proteomics. 2011 Jul;11(14):2777-89. doi: 10.1002/pmic.201000544. Epub 2011 Jun 14. Proteomics. 2011. PMID: 21674798
-
Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis.Hepatology. 2010 Apr;51(4):1190-9. doi: 10.1002/hep.23486. Hepatology. 2010. PMID: 20162621
-
Modulation of hepatic steatosis by dietary fatty acids.World J Gastroenterol. 2014 Feb 21;20(7):1746-55. doi: 10.3748/wjg.v20.i7.1746. World J Gastroenterol. 2014. PMID: 24587652 Free PMC article. Review.
-
Fatty acid-regulated transcription factors in the liver.Annu Rev Nutr. 2013;33:249-69. doi: 10.1146/annurev-nutr-071812-161139. Epub 2013 Mar 22. Annu Rev Nutr. 2013. PMID: 23528177 Free PMC article. Review.
Cited by
-
Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.Am J Pathol. 2024 Jan;194(1):71-84. doi: 10.1016/j.ajpath.2023.09.016. Epub 2023 Nov 3. Am J Pathol. 2024. PMID: 37925018
-
Human APOE4 Protects High-Fat and High-Sucrose Diet Fed Targeted Replacement Mice against Fatty Liver Disease Compared to APOE3.Aging Dis. 2024 Feb 1;15(1):259-281. doi: 10.14336/AD.2023.0530. Aging Dis. 2024. PMID: 37450924 Free PMC article.
-
Fpr2-/- Mice Developed Exacerbated Alcohol-Associated Liver Disease.Biology (Basel). 2023 Apr 23;12(5):639. doi: 10.3390/biology12050639. Biology (Basel). 2023. PMID: 37237453 Free PMC article.
-
Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS/MS.Front Pharmacol. 2023 May 4;14:1174742. doi: 10.3389/fphar.2023.1174742. eCollection 2023. Front Pharmacol. 2023. PMID: 37214449 Free PMC article.
-
Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice.FASEB J. 2023 Jan;37(1):e22705. doi: 10.1096/fj.202200778R. FASEB J. 2023. PMID: 36520060 Free PMC article.
References
-
- Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349–54. - PubMed
-
- Bullock RE, Zaitoun AM, Aithal GP, Ryder SD, Beckingham IJ, Lobo DN. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. J Hepatol. 2004;41:685–6. - PubMed
-
- Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450–5. - PubMed
-
- Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol. 2007;128:837–47. - PubMed
-
- Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40(Suppl 1):S5–S10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P20 RR016481/RR/NCRR NIH HHS/United States
- P20RR018733/RR/NCRR NIH HHS/United States
- P30 ES014443/ES/NIEHS NIH HHS/United States
- P30 ESO14443/PHS HHS/United States
- P20 RR16481/RR/NCRR NIH HHS/United States
- R01AA015970/AA/NIAAA NIH HHS/United States
- P01 AA017103/AA/NIAAA NIH HHS/United States
- P20 RR018733/RR/NCRR NIH HHS/United States
- R01DK071765/DK/NIDDK NIH HHS/United States
- R01 AA018016/AA/NIAAA NIH HHS/United States
- R01 DK071765/DK/NIDDK NIH HHS/United States
- R01 ES021375/ES/NIEHS NIH HHS/United States
- R01 AA015970/AA/NIAAA NIH HHS/United States
- R21 AA015611/AA/NIAAA NIH HHS/United States
- P01AA017103/AA/NIAAA NIH HHS/United States
- R01 AA018869/AA/NIAAA NIH HHS/United States
- R37AA010762/AA/NIAAA NIH HHS/United States
- K23 AA018399/AA/NIAAA NIH HHS/United States
- R01AA018016/AA/NIAAA NIH HHS/United States
- R37 AA010762/AA/NIAAA NIH HHS/United States
- R21AA015611/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
